Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding ...

The move is part of Roche’s previously announced plan to invest $50 billion in pharmaceuticals and diagnostics over the next ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Roche announces $550 million investment to make Indianapolis a hub for diabetes monitoring solution manufacturing. Roche expects to create hundreds of highly-skilled manufacturing jobs and thousands ...

More: Roche pours $50 billion into U.S. manufacturing; at least one new plant will be in Indiana Roche Diagnostics solidified its North American headquarters in Indianapolis in 1998 and has maintained ...

The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system.

INDIANAPOLIS (WISH) — Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana.

Officials with Roche Diagnostics announced on Monday that it will invest $550 million in its Indianapolis site by 2030. According to a news release from the company. the site ...

About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...

Roche will invest $50 billion in American manufacturing over the next five years, including building a new facility somewhere in Indiana.The Swiss biotech company said the investment will ...

Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, making the pharmaceutical giant the latest company to unveil a capital ...

INDIANAPOLIS — Roche has announced plans to invest up to $550 million in its Diagnostics facility in Indianapolis by 2030.